Release Date: 02/11/15 09:20 Summary: iSignthis completes $10.45m Capital Raising Price Sensitive: Yes Download Document 521.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%